Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2026-04-17 @ 12:38 AM
Study NCT ID:
NCT00576251
Status:
COMPLETED
Last Update Posted:
2010-03-02
First Post:
2007-12-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension
Sponsor:
Alcon Research
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
C-07-19
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Judy Vittitoe
Old Organization:
Alcon Research